These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 15217966

  • 1. Cetuximab in advanced non-small cell lung cancer.
    Govindan R.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 2):4241s-4244s. PubMed ID: 15217966
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer.
    Hanna N, Lilenbaum R, Ansari R, Lynch T, Govindan R, Jänne PA, Bonomi P.
    J Clin Oncol; 2006 Nov 20; 24(33):5253-8. PubMed ID: 17114658
    [Abstract] [Full Text] [Related]

  • 3. Is there a role for cetuximab in non small cell lung cancer?
    Morgensztern D, Govindan R.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 2):s4602-5. PubMed ID: 17671149
    [Abstract] [Full Text] [Related]

  • 4. Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor.
    Steiner P, Joynes C, Bassi R, Wang S, Tonra JR, Hadari YR, Hicklin DJ.
    Clin Cancer Res; 2007 Mar 01; 13(5):1540-51. PubMed ID: 17332300
    [Abstract] [Full Text] [Related]

  • 5. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.
    Wong SF.
    Clin Ther; 2005 Jun 01; 27(6):684-94. PubMed ID: 16117976
    [Abstract] [Full Text] [Related]

  • 6. The evolving role of cetuximab in non-small cell lung cancer.
    Lilenbaum RC.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 2):4432s-4435s. PubMed ID: 16857823
    [Abstract] [Full Text] [Related]

  • 7. Cetuximab in advanced non-small cell lung cancer.
    Rossi A, Maione P, Gridelli C.
    Crit Rev Oncol Hematol; 2006 Aug 15; 59(2):139-49. PubMed ID: 16806963
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal antibodies against EGFR in non-small cell lung cancer.
    Pirker R, Filipits M.
    Crit Rev Oncol Hematol; 2011 Oct 15; 80(1):1-9. PubMed ID: 21109448
    [Abstract] [Full Text] [Related]

  • 9. Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer.
    Ross HJ, Blumenschein GR, Aisner J, Damjanov N, Dowlati A, Garst J, Rigas JR, Smylie M, Hassani H, Allen KE, Leopold L, Zaks TZ, Shepherd FA.
    Clin Cancer Res; 2010 Mar 15; 16(6):1938-49. PubMed ID: 20215545
    [Abstract] [Full Text] [Related]

  • 10. Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer.
    Thienelt CD, Bunn PA, Hanna N, Rosenberg A, Needle MN, Long ME, Gustafson DL, Kelly K.
    J Clin Oncol; 2005 Dec 01; 23(34):8786-93. PubMed ID: 16246975
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer.
    Bunn PA, Franklin W.
    Semin Oncol; 2002 Oct 01; 29(5 Suppl 14):38-44. PubMed ID: 12422312
    [Abstract] [Full Text] [Related]

  • 12. Cetuximab in non-small-cell lung cancer.
    Carillio G, Montanino A, Costanzo R, Sandomenico C, Piccirillo MC, Di Maio M, Daniele G, Giordano P, Bryce J, Normanno N, Rocco G, Perrone F, Morabito A.
    Expert Rev Anticancer Ther; 2012 Feb 01; 12(2):163-75. PubMed ID: 22316364
    [Abstract] [Full Text] [Related]

  • 13. New molecular targeted therapies integrated with radiation therapy in lung cancer.
    Provencio M, Sánchez A, Garrido P, Valcárcel F.
    Clin Lung Cancer; 2010 Mar 01; 11(2):91-7. PubMed ID: 20199974
    [Abstract] [Full Text] [Related]

  • 14. The role of EGFR inhibition in the treatment of non-small cell lung cancer.
    Ray M, Salgia R, Vokes EE.
    Oncologist; 2009 Nov 01; 14(11):1116-30. PubMed ID: 19892771
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Current treatments for advanced stage non-small cell lung cancer.
    Stinchcombe TE, Socinski MA.
    Proc Am Thorac Soc; 2009 Apr 15; 6(2):233-41. PubMed ID: 19349493
    [Abstract] [Full Text] [Related]

  • 19. Controversies around the use of monoclonal antibodies in the treatment of advanced non-small cell lung cancer.
    Dediu M, Ion O, Ion R, Gal C, Median D, Gongu M.
    J BUON; 2009 Sep 15; 14 Suppl 1():S159-64. PubMed ID: 19785059
    [Abstract] [Full Text] [Related]

  • 20. The biological properties of cetuximab.
    Vincenzi B, Schiavon G, Silletta M, Santini D, Tonini G.
    Crit Rev Oncol Hematol; 2008 Nov 15; 68(2):93-106. PubMed ID: 18676156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.